RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $287 Price Target
Johnson & Johnson
Johnson & Johnson JNJ | 0.00 |
RBC Capital analyst Shagun Singh reiterates Johnson & Johnson (NYSE:
JNJ) with a Outperform and maintains $287 price target.
